CRM
Cardano Risk Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184M | Buy |
236,517
+11,763
| +5% | +$9.17M | 2.36% | 14 |
|
|
2025
Q1 | $186M | Buy |
224,754
+6,239
| +3% | +$5.15M | 2.95% | 12 |
|
|
2024
Q4 | $169M | Buy |
218,515
+2,143
| +1% | +$1.65M | 2.59% | 13 |
|
|
2024
Q3 | $192M | Buy |
216,372
+2,682
| +1% | +$2.38M | 3.39% | 9 |
|
|
2024
Q2 | $193M | Buy |
213,690
+36,710
| +21% | +$33.2M | 3.8% | 7 |
|
|
2024
Q1 | $138M | Buy |
176,980
+199
| +0.1% | +$155K | 4.27% | 7 |
|
|
2023
Q4 | $96.9M | Buy |
+176,781
| New | +$96.9M | 4.02% | 10 |
|